Table S3 from Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation

Table S3. IPA enriched pathways based on RNA-seq analysis</p

Table S1 from Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation

Table S1: List of primers oligos and siRNAs</p

Figures S1-S8 from Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation

Figure S1: Knockdown of MALAT1 inhibits proliferation of liver progenitor and HCC cells. Figure S2: Effect of MALAT1 expression on splicing of endogenous SRSF1 targets. Figure S3. Differential gene expression based on RNA-seq data. Figure S4. Enriched pathways and networks activated by overexpression of MALAT1 based on RNA-seq analysis. Figure S5 Enriched pathways activated by MALAT1 overexpression based on RNA-seq analysis. Figure S6. Validation of MALAT1 up- and down-regulated genes identified by RNA-seq analysis. Figure S7. Knockdown of MALAT1 down-regulates c-Myc protein levels. Figure S8. Knockdown of SRSF1 inhibits oncogenesis downstream to MALAT1 and only partially inhibits transformation by oncogenic Ras.</p

Supplementary Materials and Methods and Supplementary Figure Legends from Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation

Supplementary information text: Methods and figure legends</p

Table S2 from Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation

Table S2. Full list of Up- and Down regulated genes in the RNA seq analysis</p